Atorvastatin pleiotropic effects mediated via suppression of TNF-alpha in congestive heart failure patients with initial normal TNF-alpha levels.
Kotyla
Przemyslaw J
PJ
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D000069059:Atorvastatin; D006333:Heart Failure / Q000188:drug therapy*; D006538:Heptanoic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D023421:Models, Animal; D011758:Pyrroles / Q000009:adverse effects / Q000627:therapeutic use*; D012016:Reference Values; D014409:Tumor Necrosis Factor-alpha / Q000097:blood* / Q000187:drug effects
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D014409:Tumor Necrosis Factor-alpha; D000069059:Atorvastatin